Optimizing the Routine Use of Clinical Guidelines by Addition of Supplements (Probiotics and/or Bismuth) to

András Gelley, Noémi Kéri, Péter Birinyi, Kinga Komka, Vajk Hardy, László Döngölő, Dóra Szeli, Ibolya Czegle

Abstract read

In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Editorial: Clinical Guidelines and Real Practice of Antimicrobial Pharmacotherapy.Antibiotics (Basel, Switzerland) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

András GelleyDepartment of Internal Medicine, Gastroenterology and Endocrinology, Buda Hospital of the Hospitaller Order of Saint John of God, H-1027 Budapest, Hungary.

Noémi KériDepartment of Intensive Therapy, Faculty of Medicine, Semmelweis University, H-1085 Budapest, Hungary.

Péter BirinyiDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, H-1085 Budapest, Hungary.

Kinga KomkaDepartment of Chemical and Environmental Process Engineering, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, H-1111 Budapest, Hungary.

Vajk HardyDepartment of Internal Medicine, Gastroenterology and Endocrinology, Buda Hospital of the Hospitaller Order of Saint John of God, H-1027 Budapest, Hungary.

László DöngölőDepartment of Internal Medicine, Gastroenterology and Endocrinology, Buda Hospital of the Hospitaller Order of Saint John of God, H-1027 Budapest, Hungary.

Dóra SzeliDepartment of Internal Medicine, Gastroenterology and Endocrinology, Buda Hospital of the Hospitaller Order of Saint John of God, H-1027 Budapest, Hungary.

Ibolya CzegleDepartment of Internal Medicine and Hematology, Faculty of Medicine, Semmelweis University, H-1085 Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bismuthclinical guidelineeradication protocolHelicobacter pyloriprobiotics

Identifiers

PMID41009849

DOI10.3390/antibiotics14090870

PMCPMC12466722

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.